| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
, and Tumor Necrosis Factor
Evaluated in Gene Knockout, Tumor-bearing Mice on C57 Bl Background and Eicosanoid-dependent Cachexia1
Surgical Metabolic Research Laboratory and Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
MCG 101 tumors were implanted sc. on wild-type C57 Bl and gene knockout
mice to evaluate the role of host-produced cytokines
[interleukin (IL)-6, IL-12, IFN
, tumor necrosis factor (TNF)
receptor 1, and TNF receptor 2] to explain local tumor growth,
anorexia, and carcass weight loss in a well-defined model with
experimental cachexia. Indomethacin was provided in the drinking water
to explore interactions between host and tumor-derived prostaglandins
and proinflammatory cytokines for tumor growth. Wild-type tumor-bearing
mice developed cachexia because of rapid tumor growth, which were both
attenuated in IL-6 gene knockouts. Similar
findings were observed after provision of anti-IL-6 to wild-type
tumor-bearing mice. Alterations in food intake were not directly
related to systemic IL-6 but rather secondarily to IL-6-dependent tumor
growth. The absence of host-derived IL-12, IFN-
, or the TNF
receptor 1 or receptor 2 gene did not attenuate
tumor growth or improve subsequent cachexia. Thus, carcass weight loss
was not improved by the omission of host cytokine (TNF-
, IL-12, or
IFN-
) except for IL-6. Systemic indomethacin provision decreased
plasma prostaglandin E2 in five of six groups of gene
knockout tumor-bearing mice, which was associated with improved carcass
weight in these groups. Indomethacin seemed to improve food intake to a
similar extent in both wild-type and gene knockouts, which agree with
the speculation that eicosanoids are more important to explain anorexia
than host cytokines. Our results demonstrate that host- and
tumor-derived cytokines and prostaglandins interact with tumor growth
and promote cachexia in a more complex fashion than usually presented
based on previous information in studies on either anti-cytokine
experiments in vivo or on gene knockouts with respect to
a "single cytokine model." Overall, host cytokines were
quantitatively less important than tumor-derived cytokines to explain
net tumor growth, which indirectly explains subsequent cachexia and
anorexia.
This article has been cited by other articles:
![]() |
Y.-J. Nai, Z.-W. Jiang, Z.-M. Wang, N. Li, and J.-S. Li Prevention of Cancer Cachexia by Pyrrolidine Dithiocarbamate (PDTC) in Colon 26 Tumor-Bearing Mice JPEN J Parenter Enteral Nutr, January 1, 2007; 31(1): 18 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Wood, L. M. Nail, N. A. Perrin, C. R. Elsea, A. Fischer, and B. J. Druker The Cancer Chemotherapy Drug Etoposide (VP-16) Induces Proinflammatory Cytokine Production and Sickness Behavior-like Symptoms in a Mouse Model of Cancer Chemotherapy-Related Symptoms. Biol Res Nurs, October 1, 2006; 8(2): 157 - 169. [Abstract] [PDF] |
||||
![]() |
K. C.H. Fearon, M. D. Barber, A. G. Moses, S. H. Ahmedzai, G. S. Taylor, M. J. Tisdale, and G. D. Murray Double-Blind, Placebo-Controlled, Randomized Study of Eicosapentaenoic Acid Diester in Patients With Cancer Cachexia J. Clin. Oncol., July 20, 2006; 24(21): 3401 - 3407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. McClintock and E. M. Wagner Role of IL-6 in systemic angiogenesis of the lung J Appl Physiol, September 1, 2005; 99(3): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Martignoni, P. Kunze, W. Hildebrandt, B. Kunzli, P. Berberat, T. Giese, O. Kloters, J. Hammer, M. W. Buchler, N. A. Giese, et al. Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia Clin. Cancer Res., August 15, 2005; 11(16): 5802 - 5808. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. McCarthy Rethinking Nutritional Support for Persons with Cancer Cachexia Biol Res Nurs, July 1, 2003; 5(1): 3 - 17. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |